| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/17/2002 | EP1221950A1 Synergistic combinations of an nk 1? receptor antagonist and a gaba structural analog |
| 07/17/2002 | EP1221941A1 Powder pharmaceutical formulations |
| 07/17/2002 | EP1221939A1 Ortho ester lipids |
| 07/17/2002 | EP1221936A1 Cosmetic compositions containing mulberry extract and retinoids |
| 07/17/2002 | EP1221933A2 Composition, especially a cosmetic composition, containing a steroid and a liposoluble uv filter |
| 07/17/2002 | EP1221847A1 Methods of enhancing chemotherapy |
| 07/17/2002 | EP1073440A4 sPLA 2 INHIBITOR ESTER |
| 07/17/2002 | EP1066293B1 New porphyrins and their use |
| 07/17/2002 | EP1066056B1 An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition |
| 07/17/2002 | EP1049670B1 Azetidinecarboxamide derivatives for treating cns disorders |
| 07/17/2002 | EP1042353B1 17beta-aryl (arylmethyl) oxy(thio)alkyl -androstane derivatives |
| 07/17/2002 | EP1042327A4 A process for the reduction of oxiranyl epothilones to olefinic epothilones |
| 07/17/2002 | EP0888340B1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 07/17/2002 | EP0882044B1 1,4-dihydropyridine compounds as bradykinin antagonists |
| 07/17/2002 | EP0817637B1 Synergistic combinations of zidovudine, 1592u89 and 3tc |
| 07/17/2002 | EP0801568B1 Compounds for inhibition of ceramide-mediated signal transduction |
| 07/17/2002 | EP0766668B1 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudormophs thereof |
| 07/17/2002 | EP0749452B1 Polymer-conjugated malonic acid derivatives and their use as medicaments and diagnostic agents |
| 07/17/2002 | EP0686156B1 Pyrazolitriazines with interleukin-1 and tumour necrosis factor inhibitory activity |
| 07/17/2002 | CN1359390A Factor VII a inhibitors |
| 07/17/2002 | CN1359389A Substantially crystalline form of melagatran |
| 07/17/2002 | CN1359381A Thiazole-derivaties |
| 07/17/2002 | CN1359380A Diaminothiazoles and their use for inhibiting protein kinases |
| 07/17/2002 | CN1359378A 2-oxy-benzoxazine derivatives for the treatment of obesity |
| 07/17/2002 | CN1359371A Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 07/17/2002 | CN1359303A Pharmaceutical complex |
| 07/17/2002 | CN1359299A Keratinocyte growth factor-2-formulations |
| 07/17/2002 | CN1359297A Method for preventing tumoral growth |
| 07/17/2002 | CN1359294A Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel |
| 07/17/2002 | CN1359293A Pharmaceutical compositions comprising dipeptidy peptidase in inhibitors for the promotion of growth |
| 07/17/2002 | CN1359289A Selective iGLuR5 receptor antagonists for the treatment of migraine |
| 07/17/2002 | CN1359287A Cosmetic skin care compositions containing cumic alcohol |
| 07/17/2002 | CN1359285A Topically applied idebenone-containing agent with protective and regenerative effect |
| 07/17/2002 | CN1358723A Novel bicyclic amino-pyrazino ketone compound, its preparation method and medicinal composition having same |
| 07/17/2002 | CN1358543A Recombination plasmid and application in disease prevention and control |
| 07/17/2002 | CN1358523A Toxic substance removing ointment |
| 07/17/2002 | CN1358499A Animal phisiologicla and biological activity regulation agent composition containing cysteamine and its salt |
| 07/17/2002 | CN1087741C New indole and inidazole compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/17/2002 | CN1087740C New benzimidzole, benzoxazole and benzothiazole compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/17/2002 | CN1087737C Dihygropyridine derivatives as bradykinin ant agonists |
| 07/17/2002 | CN1087631C Radiolabeled peptides for diagnosis and therapy |
| 07/17/2002 | CN1087609C Chalcones and esters thereof with antiproliferative activity ini uterus, ovary and breast tumours |
| 07/17/2002 | CA2367825A1 Antithrombin iii for disorders caused by angiogenesis |
| 07/16/2002 | US6420591 Carbamates and compositions thereof, and methods for their use for treating cancer, inflammation, or a viral infection |
| 07/16/2002 | US6420567 Prodrugs |
| 07/16/2002 | US6420563 Inverse antagonist |
| 07/16/2002 | US6420561 Piperazinyl or piperidinyl acid derivatives for treatment of rheumatic diseases, arthritis due to gout and antiinflammatory agents |
| 07/16/2002 | US6420542 Tie ligands |
| 07/16/2002 | US6420531 Polypeptides prepared by expressing in a host cell a dna code with amino acid sequence |
| 07/16/2002 | US6420525 Human transcription factor ZGCL-1 |
| 07/16/2002 | US6420520 Peptides and remedy for bone diseases containing the same as active ingredient |
| 07/16/2002 | US6420431 Methods for treating disordered tissue through agitated delivery of anti-infective compositions |
| 07/16/2002 | US6420430 Use of benzoylguanidine derivatives to prevent aging disorders |
| 07/16/2002 | US6420427 Prevention and/or treatment of rheumatoid diseases, arthrosteitis, unusual bone resorption, osteoporosis, periodontitis, interstitial nephritis, arteriosclerosis, pulmonary emphysema, cirrhosis, cornea injury |
| 07/16/2002 | US6420424 CCR-3 receptor antagonists |
| 07/16/2002 | US6420420 Method for increasing the concentration of ascorbic acid in brain tissue of a subject |
| 07/16/2002 | US6420414 Amino derivatives of EM-138 and methods of treating angiogenesis with same |
| 07/16/2002 | US6420408 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 07/16/2002 | US6420402 Blocking of associated non-inactivating sodium channels in retinal ganglion cells in order to limit sodium/calcium exchange in retinal ganglion cells and prevent buildup of calcium level in retinal ganglion cells to a lethal level |
| 07/16/2002 | US6420399 Topical ophthalmic mast cell stabilizers for treating allergic eye disease |
| 07/16/2002 | US6420395 Disorders or diseases involving the cholinergic system of the central nervous system, pain, inflammatory diseases, diseases caused by smooth muscle contractions and as assistance in the cessation of chemical substance abuse. |
| 07/16/2002 | US6420393 Nuclear factor .kappa.b-dependent disease selected from the group consisting of inflammatory diseases, immunological disorders, septic shock, transplant rejection, radiation damage, reperfusion injuries after ischemia, stroke or |
| 07/16/2002 | US6420392 Paf receptor antagonists and/or by inhibiting the enzyme 5-lipoxygenase. |
| 07/16/2002 | US6420387 Antitumor |
| 07/16/2002 | US6420382 Tyrosine kinase inhibitors |
| 07/16/2002 | US6420373 9-N-Bicyclic nuceoside agents useful as selective inhibitors of proinflammatory cytokines |
| 07/16/2002 | US6420371 Angiogenesis inhibitor |
| 07/16/2002 | US6420368 Thienopyrimidines |
| 07/16/2002 | US6420359 5,11-Dihydro-11-ethyl-5-methyl-8-(2-((1-oxido-4-quinolinyl)oxy)ethyl)-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one for example; antiviral agents for HIV infection |
| 07/16/2002 | US6420341 Treating vasoconstrictor and hypertension effects in warm-blooded animals |
| 07/16/2002 | US6420340 Homogeneous preparation of protein, e.g. leptin, modified at the n-terminal only by an anhydride, e.g. succinic anhydride, ethylenediaminetetraacetic dianhydride; improved solubility; no inflammation at injection sites |
| 07/16/2002 | US6420335 Cancer therapy; angiostatin or endostatin to sensitize tumor endothelial cells to ionizing radiation |
| 07/16/2002 | US6420161 Nucleotide sequences coding enzymatic polypeptide for use in screening bactericides |
| 07/16/2002 | US6420157 Expression vector coding enzymatic polypeptide for use in the treatment of inflammation and sexual disorders; for use in laundry detergents |
| 07/16/2002 | US6420150 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 07/16/2002 | US6420118 Monitoring activity of mutant tumor suppressor protein; obtain sample containing mutant peptide, incubate with wild type cell, monitor tumor suppression activity of cells |
| 07/16/2002 | US6419924 Prevent membrane formation; antiproliferative agents; antitumor agents |
| 07/16/2002 | US6419710 Mixture containing oxidoreductase enzyme |
| 07/16/2002 | CA2286296C Inhibitors for urokinase receptor |
| 07/16/2002 | CA2268773C Skin battery cosmetic composition |
| 07/16/2002 | CA2240846C Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 07/16/2002 | CA2205998C Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands |
| 07/16/2002 | CA2197702C Use of a 2-amino-alkane-1,3-diol to slow loss of hair and/or stimulate or induce hair growth |
| 07/16/2002 | CA2131383C Wound healing and treatment of fibrotic disorders |
| 07/11/2002 | WO2002054064A2 Method for screening for progesterone receptor isoform-specific ligands |
| 07/11/2002 | WO2002053770A2 Method for the prediction of the risk potential for cancerous diseases and inflammatory intestinal diseases and corresponding tests |
| 07/11/2002 | WO2002053743A2 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 07/11/2002 | WO2002053742A2 Proteins and nucleic acids encoding same |
| 07/11/2002 | WO2002053740A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/11/2002 | WO2002053711A2 Use of transcription factor yb-1 in adenoviral systems |
| 07/11/2002 | WO2002053594A2 Inhibitors of memapsin 2 and use thereof |
| 07/11/2002 | WO2002053593A1 Novel g protein-coupled receptor protein and dna thereof |
| 07/11/2002 | WO2002053584A1 Stabilized pharmaceutical composition in lyophilized form |
| 07/11/2002 | WO2002053580A2 Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 07/11/2002 | WO2002053573A1 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 07/11/2002 | WO2002053568A1 Cholesterol biosynthesis inhibitors containing as the active ingredient tricyclic spiro compounds |
| 07/11/2002 | WO2002053565A1 Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient |
| 07/11/2002 | WO2002053564A2 Quinuclidine derivatives and their use as m3 antagonists |
| 07/11/2002 | WO2002053561A1 Excitatory amino acid receptor antagonists |
| 07/11/2002 | WO2002053559A1 Sodium channel modulators derived from 2-piperidylimidazoles |